211 related articles for article (PubMed ID: 16497414)
1. New potent 5-nitrofuryl derivatives as inhibitors of Trypanosoma cruzi growth. 3D-QSAR (CoMFA) studies.
Aguirre G; Boiani M; Cabrera E; Cerecetto H; Di Maio R; González M; Denicola A; Sant'anna CM; Barreiro EJ
Eur J Med Chem; 2006 Apr; 41(4):457-66. PubMed ID: 16497414
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi of 5-nitrofuryl containing thiosemicarbazones.
Aguirre G; Boiani L; Cerecetto H; Fernández M; González M; Denicola A; Otero L; Gambino D; Rigol C; Olea-Azar C; Faundez M
Bioorg Med Chem; 2004 Sep; 12(18):4885-93. PubMed ID: 15336268
[TBL] [Abstract][Full Text] [Related]
3. New potent 5-substituted benzofuroxans as inhibitors of Trypanosoma cruzi growth: quantitative structure-activity relationship studies.
Aguirre G; Boiani L; Boiani M; Cerecetto H; Di Maio R; González M; Porcal W; Denicola A; Piro OE; Castellano EE; Sant'Anna CM; Barreiro EJ
Bioorg Med Chem; 2005 Dec; 13(23):6336-46. PubMed ID: 16202608
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V
Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of new growth inhibitors of Trypanosoma cruzi (epimastigotes).
Schvartzapel AJ; Zhong L; Docampo R; Rodriguez JB; Gros EG
J Med Chem; 1997 Jul; 40(15):2314-22. PubMed ID: 9240347
[TBL] [Abstract][Full Text] [Related]
6. Second generation of 5-ethenylbenzofuroxan derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and structure-activity relationships.
Porcal W; Hernández P; Aguirre G; Boiani L; Boiani M; Merlino A; Ferreira A; Maio RD; Castro A; González M; Cerecetto H
Bioorg Med Chem; 2007 Apr; 15(7):2768-81. PubMed ID: 17287123
[TBL] [Abstract][Full Text] [Related]
7. Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets.
Otero L; Vieites M; Boiani L; Denicola A; Rigol C; Opazo L; Olea-Azar C; Maya JD; Morello A; Krauth-Siegel RL; Piro OE; Castellano E; González M; Gambino D; Cerecetto H
J Med Chem; 2006 Jun; 49(11):3322-31. PubMed ID: 16722651
[TBL] [Abstract][Full Text] [Related]
8. New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
Bollini M; Casal JJ; Alvarez DE; Boiani L; González M; Cerecetto H; Bruno AM
Bioorg Med Chem; 2009 Feb; 17(4):1437-44. PubMed ID: 19168363
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of naphthofuranquinones with activity against Trypanosoma cruzi.
Silva RS; Costa EM; Trindade UL; Teixeira DV; Pinto Mde C; Santos GL; Malta VR; De Simone CA; Pinto AV; de Castro SL
Eur J Med Chem; 2006 Apr; 41(4):526-30. PubMed ID: 16500733
[TBL] [Abstract][Full Text] [Related]
10. Platinum(II) metal complexes as potential anti-Trypanosoma cruzi agents.
Vieites M; Otero L; Santos D; Toloza J; Figueroa R; Norambuena E; Olea-Azar C; Aguirre G; Cerecetto H; González M; Morello A; Maya JD; Garat B; Gambino D
J Inorg Biochem; 2008; 102(5-6):1033-43. PubMed ID: 18226837
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi.
Cinque GM; Szajnman SH; Zhong L; Docampo R; Schvartzapel AJ; Rodriguez JB; Gros EG
J Med Chem; 1998 Apr; 41(9):1540-54. PubMed ID: 9554887
[TBL] [Abstract][Full Text] [Related]
12. Platinum-based complexes of bioactive 3-(5-nitrofuryl)acroleine thiosemicarbazones showing anti-Trypanosoma cruzi activity.
Vieites M; Otero L; Santos D; Olea-Azar C; Norambuena E; Aguirre G; Cerecetto H; González M; Kemmerling U; Morello A; Diego Maya J; Gambino D
J Inorg Biochem; 2009 Mar; 103(3):411-8. PubMed ID: 19187969
[TBL] [Abstract][Full Text] [Related]
13. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies.
Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD
J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735
[TBL] [Abstract][Full Text] [Related]
14. Imidazolidines as new anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
Caterina MC; Perillo IA; Boiani L; Pezaroglo H; Cerecetto H; González M; Salerno A
Bioorg Med Chem; 2008 Mar; 16(5):2226-34. PubMed ID: 18083035
[TBL] [Abstract][Full Text] [Related]
15. Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi.
da Silva EN; Menna-Barreto RF; Pinto Mdo C; Silva RS; Teixeira DV; de Souza MC; De Simone CA; De Castro SL; Ferreira VF; Pinto AV
Eur J Med Chem; 2008 Aug; 43(8):1774-80. PubMed ID: 18045742
[TBL] [Abstract][Full Text] [Related]
16. Trypanocidal activity of 5,6-dihydropyran-2-ones against free trypomastigotes forms of Trypanosoma cruzi.
de Fátima A; Marquissolo C; de Albuquerque S; Carraro-Abrahão AA; Pilli RA
Eur J Med Chem; 2006 Oct; 41(10):1210-3. PubMed ID: 16815596
[TBL] [Abstract][Full Text] [Related]
17. Effect of ruthenium complexation on trypanocidal activity of 5-nitrofuryl containing thiosemicarbazones.
Pagano M; Demoro B; Toloza J; Boiani L; González M; Cerecetto H; Olea-Azar C; Norambuena E; Gambino D; Otero L
Eur J Med Chem; 2009 Dec; 44(12):4937-43. PubMed ID: 19783078
[TBL] [Abstract][Full Text] [Related]
18. Studies of trypanocidal (inhibitory) power of naphthoquinones: evaluation of quantum chemical molecular descriptors for structure-activity relationships.
Paulino M; Alvareda EM; Denis PA; Barreiro EJ; Sperandio da Silva GM; Dubin M; Gastellú C; Aguilera S; Tapia O
Eur J Med Chem; 2008 Oct; 43(10):2238-46. PubMed ID: 18276039
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro trypanocidal activity of some novel iron chelating agents.
Singh PK; Jones MM; Lane JE; Nesset A; Zimmerman LJ; Ribeiro-Rodrigues R; Richter A; Stenger MR; Carter CE
Arzneimittelforschung; 1997 Mar; 47(3):311-5. PubMed ID: 9105552
[TBL] [Abstract][Full Text] [Related]
20. Nitrofurylsemicarbazone rhenium and ruthenium complexes as anti-trypanosomal agents.
Otero L; Aguirre G; Boiani L; Denicola A; Rigol C; Olea-Azar C; Maya JD; Morello A; González M; Gambino D; Cerecetto H
Eur J Med Chem; 2006 Nov; 41(11):1231-9. PubMed ID: 16828524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
